-
Real-World Treatment Patterns and Overall Survival (OS) of Patients with Metastatic Castration-Resistant Prostate Cancer in Italy
11 Nov 2025 00:02 GMT
… prostate cancer, non-metastatic castration-resistant prostate cancer, and metastatic castration-resistant prostate cancer … advanced prostate cancer: report of the advanced prostate cancer … or mitoxantrone plus prednisone for advanced prostate cancer: updated …
-
Advances in PSMA-Targeted Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
01 Sep 2025 08:17 GMT
… with abiraterone, enzalutamide, mitoxantrone, or cabazitaxel ( … metastatic castration-resistant prostate cancer: an international … castration resistant prostate cancer after chemotherapy, … prostate cancer-a systematic review and meta-analysis. Prostate Cancer …
-
Metastatic Prostate Cancer Market Size Worth $12.16 Billion by 2029 - Exclusive Report by The Business Research Company
21 Aug 2025 13:16 GMT
… Prostate Cancer Market?
The metastatic prostate cancer … Prostate Cancer Market Share?
The metastatic prostate cancer … Docetaxel, Cabazitaxel, Mitoxantrone, Combination Chemotherapy Regimens … prostate-cancer-diagnostics-global-market-report
Prostate Cancer …
-
Hormone Refractory Prostate Cancer Market to Reach $11.91 Billion by 2029 with 10% CAGR
21 Aug 2025 13:16 GMT
… :
1) By Chemotherapy: Docetaxel, Cabazitaxel, Mitoxantrone, Estramustin
2) By Hormonal Therapy … /report/prostate-cancer-drugs-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics …
-
Leading Driver In The Prostate Cancer Therapeutics Market 2025: Surge In Aging Population And Increased Life Expectancy
19 Jun 2025 11:33 GMT
… surge in the prostate cancer therapeutics market. Prostate cancer is a … Is The Prostate Cancer Therapeutics Market Segmented?
The prostate cancer therapeutics market … Chemotherapy: Docetaxel, Cabazitaxel, Mitoxantrone, Combination Chemotherapy Regimens
3 …
-
Medication Prescription Policy for US Veterans With Metastatic Castration-Resistant Prostate Cancer: Causal Machine Learning Approach.
23 Dec 2024 08:10 GMT
Prostate cancer is the second leading … treated at an early stage, prostate cancer is often curable. However, … such as metastatic castration-resistant prostate cancer (mCRPC) has a high … were on docetaxel, cabaxitaxel, mitoxantrone, and sipuleucel-T either before …
-
Crosstalk Between Extracellular Vesicles and Regulatory T Cells Across Cancers: From Interaction to Therapeutic Potential
08 Dec 2025 08:27 GMT
… treated PANC-02 cells with mitoxantrone to acquire exosomes (MEXO), then … or without vaccination in localized prostate cancer. Clin Cancer Res. 2020;26 …
-
Talazoparib/Enzalutamide Combo Offers Significant Survival Benefits in Prostate Cancer
10 Oct 2024 19:18 GMT
… metastatic castration-resistant prostate cancer (mCRPC), according to … with metastatic castration-resistant prostate cancer,” said Neeraj Agarwal, … inhibitor, cyclophosphamide, or mitoxantrone for prostate cancer; clinically significant cardiovascular …
-
NCCN 2024 Prostate Cancer Guidelines Update: PARP Inhibitors in Focus - Rashid Sayyid & Zachary Klaassen
18 Jun 2024 22:52 GMT
… Key Updates to the NCCN Prostate Cancer Guidelines that were published on … such as docetaxel, cabazitaxel, and mitoxantrone. We also have immunotherapy agents … ARPIs for metastatic hormone-sensitive prostate cancer in 3% of the population …
-
Targeted Ultrasound Nanobubbles Therapy for Prostate Cancer via Immuno-Sonodynamic Effect
18 Mar 2024 13:18 GMT
… or mitoxantrone plus prednisone for advanced prostate cancer. N … hormone-sensitive metastatic prostate cancer: evidences and uncertainties … complexity of the prostate cancer microenvironment influences the … molecular imaging of prostate cancer with PSMA-targeted …
About
© 1995-2025